This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (19)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Macular Photocoagulation Study Group

Arch Ophthalmol. 1989;107(3):344-352.

Abstract
• Persistence and recurrence of choroidal neovascularization after initial treatment with laser photocoagulation have been shown to be major contributors to loss of visual acuity. The 144 eyes assigned to krypton red laser photocoagulation in the Ocular Histoplasmosis Study-Krypton Laser were examined to describe persistence and recurrence in these patients. Persistent neovascularization was observed among 23% of treated patients and recurrent neovascularization was observed among an additional 8%. Both persistence and recurrence were accompanied by an increased frequency of severe visual loss. Patients with high blood pressure were more than 2.5 times as likely to have persistent neovascularization as patients without high blood pressure (95% confidence interval = 1.5, 4.8). Eyes in which the neovascular component of the complex was within 200 µm of the center of the foveal avascular zone were twice as likely to have persistent neovascularization (95% confidence interval = 1.2, 4.6). Eyes in which the treatment did not cover the neovascularization completely or did not meet the required level of intensity on the foveal side had a persistence rate approximately three times that of eyes in which the neovascularization was covered completely by intense, confluent burns (95% confidence interval = 1.7, 6.5). This last finding is of particular importance for ophthalmologists who treat similar patients.

Footnotes
Accepted for publication Dec 27, 1988.

Prepared for the Macular Photocoagulation Study Group by Maureen G. Maguire, PhD; James C. Folk, MD; Lawrence J. Singerman, MD; Andrew P. Schachat, MD; Dawn W. Blackhurst, MS; Judith A. Chamberlin; Neil M. Bressler, MD; Stuart L. Fine, MD; Barbara S. Hawkins, MS; and Michael J. Elman, MD. A list of all centers and selected committees is provided at the end of this report.

Reprint requests to Macular Photocoagulation Study Coordinating Center, 550 N Broadway, Ninth Floor, Baltimore, MD 21205 (Barbara S. Hawkins, MS).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Photodynamic Therapy With Verteporfin: Observations on the Introduction of a New Treatment Into Clinical Practice
Schein et al.
Arch Ophthalmol 2005;123:58-63.
ABSTRACT | FULL TEXT  

Surgical Removal vs Observation for Subfoveal Choroidal Neovascularization, Either Associated With the Ocular Histoplasmosis Syndrome or Idiopathic: I. Ophthalmic Findings From a Randomized Clinical Trial: Submacular Surgery Trials (SST) Group H Trial: SST Report No. 9
Submacular Surgery Trials Research Group
Arch Ophthalmol 2004;122:1597-1611.
ABSTRACT | FULL TEXT  

Monoclonal Antibody-Mediated Drug Targeting to Choroidal Neovascularization in the Rat
Kamizuru et al.
IOVS 2001;42:2664-2672.
ABSTRACT | FULL TEXT  

Immunosuppressive Treatment of Choroidal Neovascularization Associated With Endogenous Posterior Uveitis
Dees et al.
Arch Ophthalmol 1998;116:1456-1461.
ABSTRACT | FULL TEXT  

Submacular Surgery: New Information, More Questions
Bressler
Arch Ophthalmol 1997;115:1071-1072.
ABSTRACT  

Macular Scatter ('Grid') Laser Treatment of Poorly Demarcated Subfoveal Choroidal Neovascularization in Age-Related Macular Degeneration: Results of a Randomized Pilot Trial
Bressler et al.
Arch Ophthalmol 1996;114:1456-1464.
ABSTRACT  

Submacular Surgery: Are Randomized Trials Necessary?
Bressler
Arch Ophthalmol 1995;113:1557-1560.
ABSTRACT  

Long-term Results of Laser Treatment in the Ocular Histoplasmosis Syndrome
Cummings et al.
Arch Ophthalmol 1995;113:465-468.
ABSTRACT  

The Influence of Treatment Extent on the Visual Acuity of Eyes Treated With Krypton Laser for Juxtafoveal Choroidal Neovascularization
Macular Photocoagulation Study Group
Arch Ophthalmol 1995;113:190-194.
ABSTRACT  

Detecting Recurrent Choroidal Neovascularization: Comparison of Clinical Examination With and Without Fluorescein Angiography
Sykes et al.
Arch Ophthalmol 1994;112:1561-1566.
ABSTRACT  

10 Years: Over 10 000 Manuscripts
Goldberg
Arch Ophthalmol 1994;112:749-751.
ABSTRACT  

Persistent and Recurrent Neovascularization After Laser Photocoagulation for Subfoveal Choroidal Neovascularization of Age-Related Macular Degeneration
Macular Photocoagulation Study Group
Arch Ophthalmol 1994;112:489-499.
ABSTRACT  

Laser Photocoagulation for Juxtafoveal Choroidal Neovascularization: Five-Year Results From Randomized Clinical Trials
Macular Photocoagulation Study Group
Arch Ophthalmol 1994;112:500-509.
ABSTRACT  

Does Wavelength Matter When Photocoagulating Eyes With Macular Degeneration or Diabetic Retinopathy?
Bressler
Arch Ophthalmol 1993;111:177-180.
ABSTRACT  

Laser Photocoagulation of Subfoveal Recurrent Neovascular Lesions in Age-Related Macular Degeneration: Results of a Randomized Clinical Trial
Macular Photocoagulation Study Group
Arch Ophthalmol 1991;109:1232-1241.
ABSTRACT  

Subfoveal Neovascular Lesions in Age-Related Macular Degeneration: Guidelines for Evaluation and Treatment in the Macular Photocoagulation Study
Macular Photocoagulation Study Group
Arch Ophthalmol 1991;109:1242-1257.
ABSTRACT  

Hypertension and Visual Outcome in the Macular Photocoagulation Study
Jampol
Arch Ophthalmol 1991;109:789-790.
ABSTRACT  

Krypton Laser Photocoagulation for Neovascular Lesions of Age-Related Macular Degeneration: Results of a Randomized Clinical Trial
Macular Photocoagulation Study Group
Arch Ophthalmol 1990;108:816-824.
ABSTRACT  

Persistent and Recurrent Neovascularization After Krypton Laser Photocoagulation for Neovascular Lesions of Age-Related Macular Degeneration: Macular Photocoagulation Study Group
Arch Ophthalmol 1990;108:825-831.
ABSTRACT  

Krypton Laser Photocoagulation for Idiopathic Neovascular Lesions: Results of a Randomized Clinical Trial
Macular Photocoagulation Study Group
Arch Ophthalmol 1990;108:832-837.
ABSTRACT  

Partial Ablation of Neovascular Membranes Involving the Fovea
Tornambe and Poliner
Arch Ophthalmol 1989;107:955-956.
ABSTRACT